---
title: "RC: In 2024, the net profit is expected to be 426 million yuan, a year-on-year increase of 17.61%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236803480.md"
description: "RC announced that the operating revenue for 2024 is expected to be 5.687 billion yuan, a year-on-year increase of 7.74%. The net profit attributable to shareholders of the listed company is expected to be 426 million yuan, a year-on-year increase of 17.61%. The basic earnings per share is expected to be 1.86 yuan/share, a year-on-year increase of 17.61%. The company plans to distribute a cash dividend of 3.7 yuan for every 10 shares to all shareholders, with no bonus shares, and to increase capital reserves by 0 shares for every 10 shares to all shareholders"
datetime: "2025-04-21T13:13:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236803480.md)
  - [en](https://longbridge.com/en/news/236803480.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236803480.md)
generator: "portal-rs"
---

# RC: In 2024, the net profit is expected to be 426 million yuan, a year-on-year increase of 17.61%

RC announced that the operating revenue for 2024 is expected to be 5.687 billion yuan, a year-on-year increase of 7.74%. The net profit attributable to shareholders of the listed company is 426 million yuan, a year-on-year increase of 17.61%. The basic earnings per share is 1.86 yuan/share, a year-on-year increase of 17.61%. The company plans to distribute a cash dividend of 3.7 yuan for every 10 shares to all shareholders, with 0 bonus shares, and to convert 0 shares from the capital reserve to all shareholders for every 10 shares

### Related Stocks

- [300596.CN](https://longbridge.com/en/quote/300596.CN.md)

## Related News & Research

- [10:17 ETDarkforce™ advances toward FedRAMP High for government deployment](https://longbridge.com/en/news/297666526.md)
- [16:48 ETBeverly Hills MD Dermal Repair Complex Wins Beauty Product of the Year](https://longbridge.com/en/news/297957835.md)
- [Amwins acquires firearms industry insurer Joseph Chiarello & Co](https://longbridge.com/en/news/297783573.md)
- [03:32 ETLundbeck to highlight mechanistic insights on bexicaserin's dual mode of action at the European Epilepsy Congress](https://longbridge.com/en/news/297876004.md)
- [The Zoox Safety Case Framework](https://longbridge.com/en/news/297727873.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**